COST EFFECTIVENESS ANALYSIS OF ALEMTUZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH MULTIPLE SCLEROSIS IN CYPRUS

Authors
Category Systematic review
JournalValue in Health
Year 2018
This article has no abstract
Epistemonikos ID: 6f58b72d2ca32e73ff069b7f5b37db4aa5125855
First added on: Feb 09, 2025